Scale and reach Renal Advantage merged with Liberty Dialysis to become the third largest outpatient dialysis provider in the US, presenting a broader footprint and cross-selling opportunities across 18 states and 156 centers.

Integrated services In addition to dialysis, RAI operates RenaLab, a clinical laboratory, offering potential for bundled or complementary lab testing services and lab partnerships with hospitals and clinics.

Financial potential Current revenue range sits between 50M and 100M with a mid-sized employee base, indicating room for targeted efficiency improvements, equipment modernization, and expanded payer mix optimization.

Growth opportunities Post-merger expansion momentum coupled with a large patient base (approximately 12,000 patients) creates opportunities to offer advanced care services, home dialysis programs, and value-based care pilots.

Strategic partnerships With a substantial network across 18 states, there is potential to pursue enterprise-level partnerships, supplier consolidations, and technology integrations to streamline operations and supply chain.